1. Home
  2. ROCK vs CGON Comparison

ROCK vs CGON Comparison

Compare ROCK & CGON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROCK
  • CGON
  • Stock Information
  • Founded
  • ROCK 1972
  • CGON 2010
  • Country
  • ROCK United States
  • CGON United States
  • Employees
  • ROCK N/A
  • CGON N/A
  • Industry
  • ROCK
  • CGON
  • Sector
  • ROCK
  • CGON
  • Exchange
  • ROCK Nasdaq
  • CGON NYSE
  • Market Cap
  • ROCK 1.5B
  • CGON 1.3B
  • IPO Year
  • ROCK 1993
  • CGON 2024
  • Fundamental
  • Price
  • ROCK $58.94
  • CGON $24.91
  • Analyst Decision
  • ROCK
  • CGON Strong Buy
  • Analyst Count
  • ROCK 0
  • CGON 11
  • Target Price
  • ROCK N/A
  • CGON $62.90
  • AVG Volume (30 Days)
  • ROCK 271.8K
  • CGON 2.0M
  • Earning Date
  • ROCK 04-30-2025
  • CGON 05-16-2025
  • Dividend Yield
  • ROCK N/A
  • CGON N/A
  • EPS Growth
  • ROCK 16.71
  • CGON N/A
  • EPS
  • ROCK 4.34
  • CGON N/A
  • Revenue
  • ROCK $1,306,273,000.00
  • CGON $1,139,000.00
  • Revenue This Year
  • ROCK $11.40
  • CGON N/A
  • Revenue Next Year
  • ROCK $6.58
  • CGON $16,237.24
  • P/E Ratio
  • ROCK $13.63
  • CGON N/A
  • Revenue Growth
  • ROCK N/A
  • CGON 461.08
  • 52 Week Low
  • ROCK $48.96
  • CGON $14.80
  • 52 Week High
  • ROCK $81.90
  • CGON $40.47
  • Technical
  • Relative Strength Index (RSI)
  • ROCK 59.86
  • CGON 52.35
  • Support Level
  • ROCK $55.44
  • CGON $21.00
  • Resistance Level
  • ROCK $58.49
  • CGON $25.12
  • Average True Range (ATR)
  • ROCK 1.97
  • CGON 2.29
  • MACD
  • ROCK 1.00
  • CGON 0.12
  • Stochastic Oscillator
  • ROCK 90.70
  • CGON 38.20

About ROCK Gibraltar Industries Inc.

Gibraltar Industries Inc manufactures and provides products and services for the Renewable energy, Residential, Agtech, and Infrastructure markets. The Renewables Segment is engaged in designing, engineering, manufacturing, and installing solar racking and electrical balance systems. Agtech Segment provides growing and processing solutions including the designing, engineering, manufacturing, full-scope construction, maintenance, and support of greenhouses and indoor growing operations, and botanical extraction systems. It derives key revenue from the Residential segment which offers roof and foundation ventilation products, single point and centralized mail systems electronic package solutions, and Retractable awnings and gutter guards, among other products.

About CGON CG ONCOLOGY INC

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.

Share on Social Networks: